ANKRD30B: A Potential Drug Target and Biomarker (G374860)

Target Name: ANKRD30B

NCBI ID: G374860

ANKRD30B

ANKRD30B: A Potential Drug Target and Biomarker

ANKRD30B (AN30B_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. The ANKRD30B protein is a member of the ANKRD family, which is characterized by the presence of a hypervariable region (HVR) in the N-terminus.

The ANKRD30B protein is expressed in a variety of human tissues, including muscle, liver, and brain. It is also expressed in the placenta, which is a vital organ that plays a critical role in the development and maintenance of fetal tissue.

The ANKRD30B protein has been shown to play a role in a variety of physiological processes in the body. For example, it has been shown to be involved in the regulation of cell growth, differentiation, and survival. It has also been shown to play a role in the development and progression of a variety of diseases, including cancer.

One of the most promising aspects of ANKRD30B is its potential as a drug target. The ANKRD30B protein has been shown to be involved in a variety of cellular processes that are important for the development and progression of disease. As such, it is a potential target for a variety of therapeutic approaches, including small molecules, antibodies, and other drugs.

In addition to its potential as a drug target, ANKRD30B is also a potential biomarker. The ANKRD30B protein is expressed in a variety of human tissues and has been shown to be associated with a variety of diseases, including cancer. As such, it may be a useful biomarker for the diagnosis and treatment of these diseases.

Overall, ANKRD30B is a protein that is worth further research as a potential drug target or biomarker. Further studies are needed to fully understand its role in the body and its potential as a therapeutic approach.

Protein Name: Ankyrin Repeat Domain 30B

The "ANKRD30B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD30B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets